It Has Been A Long Farewell To The Medicines Company

 
• By Jessica Merrill

The company Novartis is buying for $9.7bn is largely unrecognizable from the one Clive Meanwell started in 1996, grew into a multi-product hospital specialist and began to sunset in 2015 with the loss of Angiomax.

Goodbye! Isolated vector illustration word - Vector
The Medicines Company will be integrated into Novartis after 23 years of business • Source: Shutterstock

More from Business

More from Scrip